Ayass BioScience, LLC
Jin Zhang is an experienced epidemiologist currently serving at Ayass BioScience, LLC since April 2021. Prior to this role, Jin held the position of Population Science Data Analyst II at UT Southwestern Medical Center's Community Prevention and Intervention Unit from December 2018 to April 2021, and worked as an Evaluation Specialist at the Mississippi Urban Research Center from 2013 until December 2018. Additional experience includes serving as a Graduate Student Intern at the University of Mississippi Medical Center and as a Research Assistant from 2009 to 2011. Jin's medical career began as a Resident Physician at The Fifth People's Hospital of Jingzhou City from 2003 to 2006. Jin holds a Master's degree in Public Health with a focus on Epidemiology and Biostatistics from Jackson State University, as well as a Master's degree in Pharmacology and Toxicology from the University of Mississippi Medical Center. Jin earned a Doctor of Medicine degree in Clinical Medicine from China Three Gorges University.
This person is not in any teams
Ayass BioScience, LLC
Ayass BioScience, LLC was established in 2014 with a mission to provide early disease detection, develop a disease monitoring system, and ultimately achieve better patient outcome by implementing Molecular Modern Medicine to daily clinical practice. We emphasize on Pathophysiology, Genetic, Epigenetic, and Proteomic/Metabolic profiling by conducting comprehensive immunologic testing, and next generation sequencing. Data collection and, more importantly, data interpretation through our bioinformatics and biostatistics department provides meaningful molecular analysis that guides precision medical practices. Our research in the field of Aptamers has opened the door to ground-breaking technology in the fields of both diagnostics and therapeutics. Our goal is to help clinicians implement unique precision medicine in their daily practice. Ayass BioScience, LLC (DBA as Ayass Lung Clinic, PLLC) is a CLIA certified laboratory performing advanced Next Generation Sequencing (Genetic Testing), Cardiac Conditions Hereditary Risk Assessment, Hereditary Cancer Risk Assessment, Neurological Conditions Genetic Predisposition Testing, also COVID-19 Testing (COVID-19 SARS-CoV-2 by RT-PCR), Pharmacogenetic Testing, Allergen Component-Resolved Testing, and Innovative Laboratory Testing. Ayass BioiScience, LLC is working on Aptamers Research and Testing. Ayass BioScience, LLC aims to be at the forefront of latest advancements in precision medicine to provide you with the most effective prevention and treatment options possible.